Skip to main content
. 2021 Mar 18;46(6):1359–1371. doi: 10.1007/s11064-021-03270-9

Fig. 4.

Fig. 4

UCP2 deficiency enhanced HT22 cell damage under OGD/R and high glucose conditions. a Light microscopy images showing morphological changes in HT22 cells treated with different concentrations of genipin (25 μM, 50 μM, 75 μM, and 100 μM). b Cell viability in HT22 cells at different concentrations was determined by CCK-8 assays. c, d The expression of UCP2 in the different groups at the indicated times was measured by western blotting. *p < 0.05 vs. the Control group. e Light microscopic images showing morphological changes in HT22 cells after different treatments. Scale bar = 20 μm. f Cell viability analysis of HT22 cells after different treatments. The experiments were repeated three times in triplicate for each condition. #p < 0.05 vs. Control; *p < 0.05 vs. HG; $p < 0.05 vs. NG + OGD/R; @p < 0.05 vs. HG + OGD/R; %p < 0.05 vs. NG + OGD/R + GE